• Psoriasis
  • Symptoms & Diagnosis
  • Types
  • Locations
  • Triggers
  • Psoriasis Treatments

  

  • Accessing Health Care
  • Resources and Tools
• Psoriatic Arthritis
  • Symptoms & Diagnosis
  • Types
  • Treatments

  

  • Accessing Health Care
  • Resources and Tools
• Research
  • Research Priorities

  • NPF-Funded Research
  • Victor Henschel BioBank
  • Science of Psoriatic Diseases

  • For Researchers

  Location:	Any Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachussetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming
  Condition:	Psoriasis Psoriatic Arthritis

• Advocacy
  • Policy Priorities
  • Take Action
  • Advocacy News and Events

  • For Policy Makers
• In Your Area
  

  • Events and Programs
  • Calendar of Events
  • Walk to Cure Psoriasis
• Get Involved
  • Walk to Cure Psoriasis
  • Donate
  • Advocate
  • Volunteer
  • Special Events
  • Calendar of Events
• Donate
  

  • Ways to Give
  • Become a Member
  • Support Research
  • Remember NPF in Your Will
  • Fundraising Events
  • Give Stock
  • Tribute and Memorial Gifts
  • Become a Professional Member

Shortage of injectable methotrexate

The Food and Drug Administration (FDA) announced a shortage of injectable methotrexate, a chemotherapy drug that was approved in the 1970s to treat severe psoriasis and psoriatic arthritis. The shortage does not affect the supply of methotrexate tablets, which is the most common version of methotrexate prescribed by dermatologists for psoriasis treatment.

The National Psoriasis Foundation recommends that people concerned about the shortage of injectable methotrexate products speak with their doctors about treatment options.

Learn more about methotrexate for psoriasis »

February 14, 2012